Organometallics
Article
Rh1B is disordered over two sites with occupancies of 0.75 and 0.25.
Two of the phenyl rings attached to B1F also exhibited orientational
disorder over two sites. TEM samples were prepared by applying a
droplet of the reaction solution onto a carbon plus Formvar coated
copper grid. The droplet was allowed to sit on the grid for 1 min, and
then the excess fluid was wicked off using filter paper. The grids were
examined in a JEOL 1400 TEM instrument operating at 100 kV.
Synthesis of the Ligand Precursors 9−11. The ligand
precursors 9−11 were all synthesized following the same procedure.
A solution of the appropriate mono- or bis(imidazolyl)benzene 1−3
(2.60 mmol) and 1-(2-bromoethyl)pyrazole (470 mg, 2.69 mmol for 1
or 950 mg, 5.43 mmol for 2 and 3) in N,N-dimethylformamide (20
mL) was refluxed for 48 h. The solvent was then removed by
distillation under vacuum and the residue dissolved in methanol (10
mL). Sodium tetraphenylborate (890 mg, 2.6 mmol for 1 or 1.78 g, 5.2
mmol for 2 and 3) was added to the solution, resulting in the
immediate formation of a pale brown precipitate. The precipitate was
filtered and recrystallized from dichloromethane/methanol for ligand
precursor 9 or from acetone/methanol for ligand precursors 10 and
11.
precipitate of the desired product. Complex 16 appeared to degrade
during recrystallization from dichloromethane, and the poor solubility
of 14 prevented recrystallization; therefore, both 14 and 16 were
washed with methanol (3 × 10 mL) and used without further
purification.
κ1-C-mono-Rh(COD) (12). Yield: 50%. 1H NMR (CDCl3, 400
MHz): δ 8.21 (d, 2H, J = 7.6 Hz, PhH), 7.52 (t, 2H, J = 7.6 Hz, PhH),
7.43 (t, 1H, J = 7.6 Hz, PhH), 7.16 (d, 1H, J = 1.7 Hz, imH), 7.00 (d,
1H, J = 1.7 Hz, imH), 5.27 (m, 1H, COD-CH), 5.14 (m, 1H, COD-
CH), 4.12 (s, 3H, CH3), 3.43 (m, 1H, COD-CH), 2.73 (m, 1H, COD-
CH), 2.26 (m, 2H, COD-CH2), 2.06 (m, 1H, COD-CH2), 1.77 (m,
3H, COD-CH2), 1.43 (m, 2H, COD-CH2) ppm. 13C{1H} NMR
(CDCl3, 100 MHz): δ 183.1 (d, JRhC = 49.3 Hz, NCN), 140.3 (PhC),
128.9 (PhC), 128.0 (PhC), 124.6 (PhC), 123.0 (imC), 121.6 (imC),
96.1 (d, JRhC = 7.5 Hz, COD-CH), 96.0 (d, JRhC = 7.5 Hz, COD-CH),
71.6 (d, JRhC = 14.3 Hz, COD-CH), 71.3 (d, JRhC = 14.3 Hz, COD-
CH), 39.4 (CH3), 33.4 (COD-CH2), 30.9 (COD-CH2), 30.1 (COD-
CH2), 28.9 (COD-CH2) ppm. Anal. Found (calcd for C18H22IN2Rh):
C, 43.63 (43.57); H, 4.55 (4.47); N, 5.67 (5.65).
κ1-C-meta-(Rh(COD))2 (13). Yield: 77%. 1H NMR (CDCl3, 300
MHz), two atropisomers identified as Ha and Hb (a/b = 0.4/0.6): δ
9.95 (t, 0.4H, J = 2.1 Hz, PhHa), 9.02 (t, 0.6H, J = 2.1 Hz, PhHb), 8.72
(dd, 0.8H, J = 8.1 and 2.1 Hz, PhHa), 8.56 (dd, 1.2H, J = 8.1 and 2.1
Hz, PhHb), 7.70 (t, 1H, J = 8.1 Hz, PhHa,b), 7.61 (d, 1.2H, J = 2.0 Hz,
imHb), 7.52 (d, 0.8H, J = 2.0 Hz, imHa), 7.08 (d, 0.8H, J = 2.0 Hz,
imHa), 7.06 (d, 1.2H, J = 2.0 Hz, imHb), 5.21 (m, 4H, COD-CHa,b),
1
κ2-C,N-mono (9). Yield: 62%. H NMR (DMSO-d6, 300 MHz): δ
9.56 (t, 1H, J = 1.6 Hz, NCHN), 8.25 (t, 1H, J = 1.9 Hz, imH), 7.72 (t,
1H, J = 1.9 Hz, imH), 7.70−7.55 (m, 6H, PhH and pzH), 7.49 (dd,
1H, J = 1.9 and 0.7 Hz, pzH), 7.17 (m, 8H, o-BPh4), 6.92 (t, 8H, J =
7.3 Hz, m-BPh4), 6.78 (t, 4H, J = 7.3 Hz, p-BPh4), 6.26 (t, 1H, J = 2.1
Hz, pzH), 4.68 (s, 4H, CH2) ppm. 13C{1H} NMR (DMSO-d6, 75
MHz): δ 163.4 (q, JBC = 49.5 Hz, BC), 139.8 (pzC), 135.8 (NCN),
135.6 (m, o-BPh4), 134.6 (PhC), 130.9 (pzC), 130.4 (PhC), 130.1
(PhC), 125.4 (q, JBC = 2.8 Hz, m-BPh4), 123.5 (imC), 121.8 (PhC),
121.6 (p-BPh4), 121.2 (imC), 105.8 (pzC), 50.3 (CH2), 49.7(CH2)
ppm. Anal. Found (calcd for C38H35BN4·0.5CH3OH): C, 80.77
(80.48); H, 6.31 (6.49); N, 10.06 (9.75). ESI-HRMS, found
(calculated): m/z 239.1289 (239.1291, [M − BPh4]+).
a
b
4.21 (s, 2.4H, CH3 ), 4.16 (s, 3.2H, CH3 ), 3.49−3.40 (m, 2H, COD-
CHa,b), 2.96−2.82 (m, 2H, COD-CHa,b), 2.52−1.35 (m, 16H, COD-
CH2a,b) ppm. 13C{1H} NMR (CDCl3, 75 MHz), atropisomers a and b
could not be distinguished between the closely spaced resonance pairs:
δ 183.4 (d, J = 49.2 Hz, NCN), 183.2 (d, J = 49.2 Hz, NCN), 140.2
(PhC), 140.0 (PhC), 129.1 (2 × PhC), 123.6 (imC), 123.5 (imC),
122.8 (PhC), 121.8 (imC), 121.4 (imC), 121.2 (PhC), 120.5 (PhC),
116.9 (PhC), 96.8 (d, J = 7.0 Hz, COD-CH), 96.2 (d, J = 7.0 Hz,
COD-CH), 95.8 (d, J = 7.0 Hz, COD-CH), 95.6 (d, J = 7.0 Hz, COD-
CH), 72.5 (d, J = 14.0 Hz, COD-CH), 72.2 (d, J = 14.0 Hz, COD-
CH), 72.1 (d, J = 14.0 Hz, COD-CH), 71.6 (d, J = 14.0 Hz, COD-
κ2-C,N-ortho (10). Yield: 66%. 1H NMR (acetone-d6, 300 MHz): δ
8.97 (t, 2H, J = 1.5 Hz, NCHN), 7.91 (m, 2H, PhH), 7.77 (m, 2H,
PhH), 7.66 (m, 4H, imH and pzH), 7.57 (t, 2H, J = 1.9 Hz, imH), 7.51
(d, 2H, J = 1.9 Hz, pzH), 7.33 (m, 16H, o-BPh4), 6.91 (t, 16H, J = 7.3
Hz, m-BPh4), 6.77 (t, 8H, J = 7.3 Hz, p-BPh4), 6.32 (t, 2H, J = 2.1 Hz,
pzH), 4.82 (m, 4H, CH2), 4.70 (m, 4H, CH2) ppm. 13C{1H} NMR
(acetone-d6, 75 MHz): δ 164.9 (q, JBC = 49.6 Hz, BC), 141.1 (pzC),
138.8 (NCN), 137.0 (m, o-BPh4), 133.9 (PhC), 131.6 (pzC), 130.9
(PhC), 129.3 (PhC), 126.1 (q, JBC = 2.8 Hz, m-BPh4), 125.1 (imC),
124.5 (imC), 122.3 (p-BPh4), 107.0 (pzC), 51.5 (2 × CH2) ppm. ESI-
HRMS, found (calculated): m/z 200.1053 (200.1057, [M −
(BPh4)2]2+), 719.3771 (719.3777, [M − BPh4]+),
a
b
CH), 39.9 (CH3 ), 39.4 (CH3 ), 33.5 (COD-CH2), 32.7 (COD-CH2),
31.7 (COD-CH2), 30.8 (COD-CH2), 30.7 (COD-CH2), 29.7 (COD-
CH2), 29.6 (COD-CH2), 28.8 (COD-CH2) ppm. Anal. Found (calcd
for C30H38I2N4Rh2·H2O): C, 38.50 (38.65); H, 4.17 (4.32); N, 5.96
(6.01).
κ1-C-para-(Rh(COD))2 (14). Yield: 80%. 1H NMR (CDCl3, 400
MHz), two atropisomers identified as Ha and Hb (a/b = 0.45/0.55): δ
8.61 (s, 2.2H, PhHb), 8.46 (s, 1.8H, PhHa), 7.28 (d, 1.1H, J = 2.0 Hz,
imHb), 2.24 (d, 0.9H, J = 2.0 Hz, imHa), 7.08 (d, 1.1H, J = 2.0 Hz,
imHb), 7.07 (d, 0.9H, J = 2.0 Hz, imHa), 5.26 (m, 4H, COD-CHa,b),
1
κ2-C,N-meta (11). Yield: 52%. H NMR (acetone-d6, 300 MHz): δ
8.93 (t, 2H, J = 1.6 Hz, NCHN), 7.96 (m, 3H, imH and PhH), 7.91
(m, 1H, PhH), 7.83 (m, 2H, PhH), 7.65 (t, 2H, J = 1.9 Hz, imH), 7.61
(dd, 2H, J = 2.3 and 0.6 Hz, pzH), 7.47 (dd, 2H, J = 1.9 and 0.6 Hz,
pzH), 7.32 (m, 16H, o-BPh4), 6.91 (t, 16H, J = 7.3 Hz, m-BPh4), 6.76
(m, 8H, p-BPh4), 6.26 (dd, 2H, J = 2.3 and1.9 Hz, pzH), 4.84 (m, 4H,
CH2), 4.73 (m, 4H, CH2) ppm. 13C{1H} NMR (acetone-d6, 75 MHz):
δ 164.9 (q, JBC = 49.6 Hz, BC), 140.9 (pzC), 137.0 (m, o-BPh4), 136.8
(PhC), 136.7 (NCN), 133.4 (PhC), 131.5 (pzC), 126.1 (q, JBC = 2.6
Hz, m-BPh4), 125.2 (PhC), 125.0 (imC), 122.9 (imC), 122.3 (p-BPh4),
118.1 (PhC), 106.9 (pzC), 51.4 (CH2), 51.3 (CH2) ppm. ESI-HRMS,
found (calculated): m/z 200.1054 (200.1057, [M − (BPh4)2]2+),
719.3779 (719.3777, [M − BPh4]+). Anal. Found (calcd for
C70H64B2N8): C, 80.61 (80.93); H, 6.33 (6.21); N, 10.89 (10.79).
Synthesis of COD-Containing Complexes 12−16. The
rhodium COD complexes 12−16 were synthesized by following the
same procedure as above. The appropriate ligand precursor 5−11
(0.88 mmol), [Rh(COD)Cl]2 (217 mg, 0.44 mmol for 12 and 15 or
434 mg, 0.88 mmol for 13, 14, and 16) and sodium ethoxide (112 mg,
1.64 mmol for 12 and 15 or 224 mg, 3.28 mmol for 13, 14, and 16)
were suspended in methanol (25 mL) and refluxed for 1 h (for
complex 16, refluxing the solution for only 30 min afforded a cleaner
product). Upon cooling to room temperature a yellow precipitate of
the product formed. Complexes 12, 13, and 15 were filtered and
recrystallized from dichloromethane/pentane to form a clean
b
a
4.20 (s, 3.3H, CH3 ), 4.17 (s, 2.7H, CH3 ), 3.49 (m, 2H, COD-CHa,b),
2.87 (m, 2H, COD-CHa,b), 2.44−1.37 (m, 16H, COD-CH2a,b) ppm.
The low solubility of 14 prevented acquisition of the 13C{1H} NMR
spectrum. Anal. Found (calcd for C30H38I2N4Rh2): C, 40.18 (39.87);
H, 4.02 (4.01); N, 6.23 (6.18).
κ2-C,N-mono-Rh(COD) (15). Yield: 80%. 1H NMR (acetone-d6, 400
MHz): δ 8.12 (d, 2H, J = 7.3 Hz, PhH), 8.04 (d, 1H, J = 2.3 Hz, pzH),
7.87 (d, 1H, J = 2.3 Hz, pzH), 7.71 (t, 2H, J = 7.3 Hz, PhH), 7.62 (t,
1H, J = 7.3 Hz, PhH), 7.52 (d, 1H, J = 2.0 Hz, imH), 7.35 (m, 9H,
imH and o-BPh4), 6.94 (m, 9H, NCH2 and m-BPh4), 6.78 (t, 4H, J =
7.3 Hz, p-BPh4), 6.47 (t, 1H, J = 2.3 Hz, pzH), 5.21 (m, 2H, NCH2
and COD-CH), 5.11 (ddd, 1H, J = 14.6, 4.6, and 3.2 Hz, NCH2), 4.68
(ddd, 1H, J = 14.6, 11.2, and 5.2 Hz, NCH2), 4.44 (q, 1H, J = 7.4 Hz,
COD-CH), 4.36 (m, 1H, COD-CH), 2.80 (m, 1H, COD-CH), 2.57
(m, 2H, COD-CH2), 2.25 (m, 1H, COD-CH2), 2.11 (m, 2H, COD-
CH2), 1.80 (m, 1H, COD-CH2), 1.56 (m, 2H, COD-CH2) ppm.
13C{1H} NMR (acetone-d6, 100 MHz): δ 176.4 (d, JRhC = 50.8 Hz,
NCN), 165.2 (q, JBC = 49.3 Hz, BC), 141.9 (pzC), 141.5 (PhC), 137.1
(m, o-BPh4), 134.9 (pzC), 130.3 (PhC), 129.8 (PhC), 126.0 (q, JBC
=
2.6 Hz, m-BPh4), 125.6 (PhC), 125.3 (imC), 123.8 (imC), 122.3 (p-
BPh4), 109.2 (pzC), 97.2 (d, JRhC = 7.9 Hz, COD-CH), 95.1 (d, JRhC
7.9 Hz, COD-CH), 80.3 (d, JRhC = 13.0 Hz, COD-CH), 74.7 (d, JRhC
=
=
13.0 Hz, COD-CH), 51.4 (NCH2), 50.3 (NCH2), 34.6 (COD-CH2),
G
Organometallics XXXX, XXX, XXX−XXX